These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

446 related articles for article (PubMed ID: 32688090)

  • 21. A pH-Responsive Charge-Reversal Drug Delivery System with Tumor-Specific Drug Release and ROS Generation for Cancer Therapy.
    Xu C; Song R; Lu P; Chen J; Zhou Y; Shen G; Jiang M; Zhang W
    Int J Nanomedicine; 2020; 15():65-80. PubMed ID: 32021165
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hyperthermal paclitaxel-bound albumin nanoparticles co-loaded with indocyanine green and hyaluronidase for treating pancreatic cancers.
    Kim SS; Kim HK; Kim H; Lee WT; Lee ES; Oh KT; Choi HG; Youn YS
    Arch Pharm Res; 2021 Feb; 44(2):182-193. PubMed ID: 32803685
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Peptide-functionalized and high drug loaded novel nanoparticles as dual-targeting drug delivery system for modulated and controlled release of paclitaxel to brain glioma.
    Di Mauro PP; Cascante A; Brugada Vilà P; Gómez-Vallejo V; Llop J; Borrós S
    Int J Pharm; 2018 Dec; 553(1-2):169-185. PubMed ID: 30321641
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Paclitaxel-loaded pH responsive hydrogel based on self-assembled peptides for tumor targeting.
    Raza F; Zhu Y; Chen L; You X; Zhang J; Khan A; Khan MW; Hasnat M; Zafar H; Wu J; Ge L
    Biomater Sci; 2019 Apr; 7(5):2023-2036. PubMed ID: 30839983
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reconstituted high density lipoprotein mediated targeted co-delivery of HZ08 and paclitaxel enhances the efficacy of paclitaxel in multidrug-resistant MCF-7 breast cancer cells.
    Zhang F; Wang X; Xu X; Li M; Zhou J; Wang W
    Eur J Pharm Sci; 2016 Sep; 92():11-21. PubMed ID: 27343697
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Novel pH-sensitive zinc phthalocyanine assembled with albumin for tumor targeting and treatment.
    Wang Y; Zheng K; Xuan G; Huang M; Xue J
    Int J Nanomedicine; 2018; 13():7681-7695. PubMed ID: 30538452
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An organic solvent-free technology for the fabrication of albumin-based paclitaxel nanoparticles for effective cancer therapy.
    Zhao Y; Cai C; Liu M; Zhao Y; Pei W; Chu X; Zhang H; Wang Z; Han J
    Colloids Surf B Biointerfaces; 2019 Nov; 183():110394. PubMed ID: 31398618
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Specific cellular internalization and pH-responsive behavior of doxorubicin loaded PLGA-PEG nanoparticles targeted with anti EGFRvIII antibody.
    Eivazi N; Rahmani R; Paknejad M
    Life Sci; 2020 Nov; 261():118361. PubMed ID: 32861796
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Charge-Convertible Carbon Dots for Imaging-Guided Drug Delivery with Enhanced in Vivo Cancer Therapeutic Efficiency.
    Feng T; Ai X; An G; Yang P; Zhao Y
    ACS Nano; 2016 Apr; 10(4):4410-20. PubMed ID: 26997431
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Layer-by-layer pH-sensitive nanoparticles for drug delivery and controlled release with improved therapeutic efficacy
    Men W; Zhu P; Dong S; Liu W; Zhou K; Bai Y; Liu X; Gong S; Zhang S
    Drug Deliv; 2020 Dec; 27(1):180-190. PubMed ID: 31924103
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Novel free-paclitaxel-loaded redox-responsive nanoparticles based on a disulfide-linked poly(ethylene glycol)-drug conjugate for intracellular drug delivery: synthesis, characterization, and antitumor activity in vitro and in vivo.
    Chuan X; Song Q; Lin J; Chen X; Zhang H; Dai W; He B; Wang X; Zhang Q
    Mol Pharm; 2014 Oct; 11(10):3656-70. PubMed ID: 25208098
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Dual pH/ROS-Responsive Nanoplatform with Deep Tumor Penetration and Self-Amplified Drug Release for Enhancing Tumor Chemotherapeutic Efficacy.
    Li Y; Chen M; Yao B; Lu X; Song B; Vasilatos SN; Zhang X; Ren X; Yao C; Bian W; Sun L
    Small; 2020 Aug; 16(32):e2002188. PubMed ID: 32627387
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Self-Assembled Tumor-Penetrating Peptide-Modified Poly(l-γ-glutamylglutamine)-Paclitaxel Nanoparticles Based on Hydrophobic Interaction for the Treatment of Glioblastoma.
    Yu J; Sun L; Zhou J; Gao L; Nan L; Zhao S; Peng T; Han L; Wang J; Lu W; Zhang L; Wang Y; Yan Z; Yu L
    Bioconjug Chem; 2017 Nov; 28(11):2823-2831. PubMed ID: 28968068
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Paclitaxel delivered by CD44 receptor-targeting and endosomal pH sensitive dual functionalized hyaluronic acid micelles for multidrug resistance reversion.
    Liu Y; Zhou C; Wei S; Yang T; Lan Y; Cao A; Yang J; Hou Y
    Colloids Surf B Biointerfaces; 2018 Oct; 170():330-340. PubMed ID: 29936386
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Tumor microenvironment-activated cancer cell membrane-liposome hybrid nanoparticle-mediated synergistic metabolic therapy and chemotherapy for non-small cell lung cancer.
    Zhang W; Gong C; Chen Z; Li M; Li Y; Gao J
    J Nanobiotechnology; 2021 Oct; 19(1):339. PubMed ID: 34689761
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Self-assembled peptide nanoparticles responsive to multiple tumor microenvironment triggers provide highly efficient targeted delivery and release of antitumor drug.
    Jiang X; Fan X; Xu W; Zhao C; Wu H; Zhang R; Wu G
    J Control Release; 2019 Dec; 316():196-207. PubMed ID: 31682910
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Surface charge-switchable polymeric magnetic nanoparticles for the controlled release of anticancer drug.
    Shen JM; Yin T; Tian XZ; Gao FY; Xu S
    ACS Appl Mater Interfaces; 2013 Aug; 5(15):7014-24. PubMed ID: 23815399
    [TBL] [Abstract][Full Text] [Related]  

  • 38. CD44 Receptor Targeting and Endosomal pH-Sensitive Dual Functional Hyaluronic Acid Micelles for Intracellular Paclitaxel Delivery.
    Liu Y; Zhou C; Wang W; Yang J; Wang H; Hong W; Huang Y
    Mol Pharm; 2016 Dec; 13(12):4209-4221. PubMed ID: 27796093
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Stepwise targeted drug delivery to liver cancer cells for enhanced therapeutic efficacy by galactose-grafted, ultra-pH-sensitive micelles.
    Yan G; Wang J; Hu L; Wang X; Yang G; Fu S; Cheng X; Zhang P; Tang R
    Acta Biomater; 2017 Mar; 51():363-373. PubMed ID: 28087485
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Poly((D,L)lactic-glycolic)acid-star glucose nanoparticles for glucose transporter and hypoglycemia-mediated tumor targeting.
    Park JH; Cho HJ; Kim DD
    Int J Nanomedicine; 2017; 12():7453-7467. PubMed ID: 29066894
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 23.